Sartorius Stedim Biotech S.A. earnings per share and revenue

56S1 earnings per share for the last quarter are 0.86 EUR whereas the estimation was 0.90 EUR which accounts for -4.43% surprise. Företagets omsättning för samma period uppgår till 666.90 M EUR trots den uppskattade siffran 718.95 M EUR. Estimated earnings per share for the next quarter are 1.06 EUR, and revenue is expected to reach 706.12 M EUR. Also watch annual changes over time to get a bigger picture of 56S1 earnings per share and revenue dynamics.